Consensus review of the clinical utility of dna cytometry in bladder cancer

Cytometry

Volumn 14, Issue 5, 1993, Pages 478-481

  Wheeless, Leon L ^a   Badalament, Robert A ^b   deVere White, Ralph W ^c   Fradet, Yves ^d   Tribukait, Bernhard ^e  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAVAL UNIVERSITY   (Canada)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CONFERENCE PAPER; CYTOMETRY; DNA CONTENT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

BLADDER NEOPLASMS; DNA, NEOPLASM; FLOW CYTOMETRY; GUIDELINES; HUMAN; PLOIDIES; PRACTICE GUIDELINES; PROGNOSIS; S PHASE;

EID: 0027288071     PISSN: 01964763     EISSN: 10970320     Source Type: Journal    
DOI: 10.1002/cyto.990140504     Document Type: Article

References (41)

1. Flow cytometric evaluation of bladder cancer: Recommendations of the NCI flow cytometry network for bladder cancer
2. The relative value of cytometry and cytology in the management of bladder cancer: The Memorial Sloan‐Kettering Cancer Center experience
3. Monitoring intravesical bacillus Calmette‐Guerin treatment of superficial bladder carcinoma by serial flow cytometry
4. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma
5. The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma
6. Flow cytometric analysis of primary and metastatic bladder cancer
7. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma
8. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma
9. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette‐Guerin
10. Urine: A suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer
11. The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer
12. Flow cytometry: Role in monitoring transitional cell carcinoma of bladder
13. A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients
14. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies: Laval University Urology Group
15. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder
16. Characterization of bladder carcinomas by flow DNA analysis
17. The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder
18. DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours
19. DNA profile and tumour progression in patients with superficial bladder tumours
20. Prophylactic instillation therapy of superficial bladder cancer
21. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue
22. Voided urine flow cytometry in screening high‐risk patients for the presence of bladder cancer
23. Detection of bladder carcinoma in females by flow cytometry and cytology
24. Flow cytometry and cytology as response indicators to M‐VAC (methotrexate, vinblastine, doxorubicin and cisplatin)
25. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy‐radiotherapy
26. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience
27. Flow cytometric study comparing paired bladder washing and voided urine for bladder cancer detection
28. Predictive value of DNA measurements in bladder washings
29. Prognosis of superficial bladder tumors as studied by DNA flow cytometry. A report on a double blind study of 120 patients
30. Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder
31. Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: A study of 63 patients with grade 3 lesions
32. Prognostic significance of mucosal aneuploidy in the stage Ta/T1 Grade 3 carcinoma of the bladder
33. Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry
34. Acridine‐orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder: The influence of prior local therapy
35. Flow cytometry in assessing the clinical aggressiveness of genito‐urinary neoplasms
36. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases
37. Precision of DNA flow cytometry in inter‐institutional analyses
38. DNA slit‐scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells
39. Urine or bladder washings in the cytologic evaluation of transitional cell carcinoma of the urinary tract: A comparison made under routine conditions supplemented by flow cytometric DNA analysis
40. Deoxyribonucleic acid flow cytometry in predicting response to radical radiotherapy of bladder cancer
41. DNA analysis in predicting survival of irradiated patients with transitional cell carcinoma of bladder